We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-2.63%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.26B
AUM Growth
-$529M
Cap. Flow
-$492M
Cap. Flow %
-21.74%
Top 10 Hldgs %
34.63%
Holding
101
New
12
Increased
22
Reduced
23
Closed
23

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$36.9M
2
DXCM icon
DexCom
DXCM
+$32.3M
3
BLUE
bluebird bio
BLUE
+$24.8M
4
ACHC icon
Acadia Healthcare
ACHC
+$24.2M
5
ASND icon
Ascendis Pharma A/S
ASND
+$23.1M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$46.8M
2
BIIB icon
Biogen
BIIB
+$43.1M
3
AZN icon
AstraZeneca
AZN
+$39.1M
4
AXSM icon
Axsome Therapeutics
AXSM
+$32M
5
A icon
Agilent Technologies
A
+$27.5M

Sector Composition

Rank Sector Weight
1 Healthcare 91.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICLR icon
51
Icon
ICLR
$12.4B
$13.8M 0.61%
64,417
-17,308
-21% -$3.85M
LLY icon
52
CALL
Eli Lilly
LLY
$1.06T
$13.6M 0.6%
+39,700
New +$13.4M
EPIX
53
DELISTED
ESSA Pharma
EPIX
$12.4M 0.55%
4,161,461
+317,129
+8% +$932K
MRTX
54
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$11.9M 0.52%
+318,948
New +$14.3M
GBIO
55
DELISTED
Generation Bio
GBIO
$11.4M 0.5%
264,830
-25,489
-9% -$1.23M
PRCT icon
56
Procept Biorobotics
PRCT
$1.14B
$9.08M 0.4%
319,782
-197,744
-38% -$6.98M
EDIT icon
57
Editas Medicine
EDIT
$445M
$7.55M 0.33%
1,040,794
-425,938
-29% -$3.79M
IMVT icon
58
Immunovant
IMVT
$8.2B
$7.17M 0.32%
+462,431
New +$8.02M
THC icon
59
CALL
Tenet Healthcare
THC
$20.7B
$6.57M 0.29%
110,600
-115,300
-51% -$6.41M
ADAP
60
DELISTED
Adaptimmune Therapeutics
ADAP
$6.53M 0.29%
5,992,571
+1,149,061
+24% +$1.78M
OM icon
61
Outset Medical
OM
$96.4M
$5.98M 0.26%
+21,665
New +$7.95M
HOWL icon
62
Werewolf Therapeutics
HOWL
$19.6M
$5.76M 0.25%
2,217,220
+923,927
+71% +$2.75M
XENE icon
63
Xenon Pharmaceuticals
XENE
$6.24B
$3.58M 0.16%
100,147
+82,659
+473% +$3.05M
CELC icon
64
Celcuity
CELC
$4.55B
$3.19M 0.14%
310,965
-401,146
-56% -$4.4M
BLU
65
DELISTED
BELLUS Health Inc.
BLU
$3.17M 0.14%
439,813
+375,949
+589% +$2.92M
VERV
66
DELISTED
Verve Therapeutics
VERV
$2.68M 0.12%
186,087
-31,215
-14% -$611K
CMPS
67
Compass Pathways
CMPS
$1.83B
$2.44M 0.11%
246,064
-263,561
-52% -$2.43M
INBX
68
DELISTED
Inhibrx, Inc. Common Stock
INBX
$2.29M 0.1%
+121,447
New +$2.82M
PMVP icon
69
PMV Pharmaceuticals
PMVP
$62.9M
$1.99M 0.09%
418,027
+84,311
+25% +$593K
PRAX icon
70
Praxis Precision Medicines
PRAX
$10.3B
$1.76M 0.08%
145,106
-40,058
-22% -$1.69M
VECT
71
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$1.12M 0.05%
131,922
+106,381
+417% +$877K
IOBT
72
DELISTED
IO Biotech
IOBT
$952K 0.04%
507,640
– –
KROS icon
73
Keros Therapeutics
KROS
$211M
$869K 0.04%
20,350
+4,351
+27% +$220K
IOVA icon
74
Iovance Biotherapeutics
IOVA
$2.77B
$868K 0.04%
142,055
+128,718
+965% +$888K
SANA icon
75
Sana Biotechnology
SANA
$949M
$45.7K ﹤0.01%
13,966
-48,810
-78% -$195K
1 2
3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
PWA
Pitcairn Wealth Advisors Conshohocken, Pennsylvania $1.09B AUM

PFM Health Sciences's Q1 2023 Portfolio in Review

As of Q1 2023, PFM Health Sciences held 101 positions worth $2.26B, down 19% from $2.79B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

PFM Health Sciences withdrew a net $492M in Q1 2023, closing 23 positions and reducing 23 holdings. Its most notable exit was Cigna, an estimated $46.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 81% a quarter earlier.

Against the trend, PFM Health Sciences opened a new position in Becton Dickinson worth $37.4M.

  • PFM Health Sciences's largest Q1 2023 buy was Becton Dickinson: 151,013 shares worth $37.4M.
  • PFM Health Sciences added most to DexCom in Q1 2023, an estimated $32.3M increase.
  • PFM Health Sciences's biggest Q1 2023 reduction was Axsome Therapeutics, cutting an estimated $32M.
  • PFM Health Sciences fully exited Cigna in Q1 2023, selling an estimated $46.8M.
  • PFM Health Sciences's ten largest holdings make up 35% of its $2.26B portfolio in Q1 2023.
  • PFM Health Sciences opened 12 new positions and closed 23 in Q1 2023.
  • PFM Health Sciences's portfolio value fell 19% quarter-over-quarter to $2.26B.

Based on PFM Health Sciences's 13F filing for Q1 2023, filed 15 May 2023.